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Research
Recent reviews of the health effects of   particulate 
matter (PM) air pollution suggest evidence of 
adverse effects on cardiovascular disease (CVD) 
outcomes [e.g., U.S. Environmental Protection 
Agency (EPA) 2009]. Although several mecha­
nisms such as oxidative stress and inflammation 
have been suggested (Brook et al. 2010; Mills 
et al. 2009), it is not clear if specific chemical 
constituents of PM play distinct roles in any 
of these mechanisms. If PM toxicity could be 
determined based on specific chemical constitu­
ents or source types that emit such constituents, 
the regulation of PM may be implemented 
more effectively. Also, if a given adverse 
health outcome is associated with specific PM 
component(s) but not with others, then a spe­
cific mechanism may be postulated for further 
consideration by toxicological studies.
Recent multicity time­series studies of PM 
have generated important information regard­
ing the possible role of sources but have also 
raised some issues that require further investi­
gation. For example, the most comprehensive 
U.S.­based multicity study of elderly hospital 
admissions (Bell et al. 2008) found the largest 
risk estimates for PM mass with aerodynamic 
diameter ≤ 2.5 µm (PM2.5; collected with a size­
selective inlet with 50% cut­point of 2.5 µm 
aerodynamic diameter) for both cardiovascular 
and respiratory hospitalizations in northeast­
ern cities and during the winter season. The 
most comprehensive U.S.­based multicity study 
(Peng et al. 2005) of all­cause mortality (of 
which nearly half are from cardiovascular causes) 
similarly found the largest PM10 (aerodynamic 
diameter ≤ 10 µm) risk estimates in the north­
eastern cities but during the summer season. 
Thus, although both the hospitalization and 
mortality multicity studies found the strongest 
associations in northeastern cities, their seasonal 
patterns of associations are not consistent.
Several studies have examined the annual 
or seasonal average levels of PM2.5 chemical 
components as potential effect modifiers in a 
  second­stage regression in order to try to explain 
city­to­city variation in short­term PM risk esti­
mates from the first­stage time­series analysis 
in individual cities. Lippmann et al. (2006) 
reported that some of the city­to­city varia­
tion in the PM10–mortality risk estimates from 
the National Morbidity, Mortality, and Air 
Pollution Study could be explained by the vari­
ation in nickel (Ni) and vanadium (V) contents 
in PM2.5 across cities. However, Dominici et al. 
(2007) pointed out, in their analysis, that such 
a finding could be highly influenced by New 
York City (NYC) data (NYC has a large popu­
lation and high Ni levels). A recent analysis by 
Bell et al. (2009) reported that the city­to­city 
variations in PM2.5 risk for both cardiovascular 
and respiratory hospitalizations among elderly 
persons were significantly modified by Ni, V, 
and elemental carbon (EC), suggesting that 
PM2.5 effects were stronger in locations with 
higher residual oil­burning–related and traffic­
related pollution, highlighting the importance 
of local combustion sources. Bell et al. (2009) 
also found that sulfate (SO4) was not a signifi­
cant predictor of city­to­city variation in PM2.5 
risks. In an analysis of 25 U.S. cities, which did 
not include NYC, Franklin et al. (2008) found 
that the PM2.5–mortality risk estimates were 
significantly modified by aluminum, arsenic, 
silicon (Si), SO4, and Ni. In their analysis of 
27 U.S. cities, Zanobetti et al. (2009) observed 
that the association between PM2.5 and CVD 
hospitalizations was significantly modified 
when the PM was high in bromine (Br), chro­
mium (Cr), Ni, and sodium ion (Na+). Overall, 
these studies show mixed results, and because 
PM2.5 chemical constituents were treated as 
effect modifiers of PM mass concentration 
effects on mortality or hospitalizations, they 
do not necessarily suggest that these individual 
chemical constituents are associated with the 
health outcomes on a day­to­day basis.
Few studies to date have examined daily 
PM chemical constituents in relation to health 
outcomes. In an analysis of Phoenix, Arizona, 
Mar et al. (2000) examined several key PM2.5 
chemical components in addition to PM2.5 
and gaseous pollutants. They found that EC 
was significantly associated with CVD mortal­
ity, but they also found similar associations 
with nitrogen dioxide (NO2), sulfur dioxide 
(SO2), carbon monoxide (CO), and PM2.5. 
Address correspondence to K. Ito, 57 Old Forge Rd., 
Tuxedo, NY 10987 USA. Telephone: (845) 731­
3540. Fax: (845) 351­5472. E­mail: ki7@nyu.edu
Supplemental  Material  is  available  online 
(doi:10.1289/ehp.1002667 via http://dx.doi.org/).
This research was supported by a grant from the 
U.S. Environmental Protection Agency Science 
to Achieve Results (R833623010) and from the 
National Institute of Environmental Health Sciences 
Center (ES00260), and in part by the Health Effects 
Institute National Particulate Component Toxicity 
Initiative (contract 4750­RFA05­1A/06­11). 
Z.R. is employed by ZevRoss Spatial Analysis 
(Ithaca, NY). The authors declare they have no actual 
or potential competing   financial interests.
Received 2 July 2010; accepted 17 December 2010.
Fine Particulate Matter Constituents Associated with Cardiovascular 
Hospitalizations and Mortality in New York City
Kazuhiko Ito,1 Robert Mathes,2 Zev Ross,3 Arthur Nádas,1 George Thurston,1 and Thomas Matte4
1New York University School of Medicine, Tuxedo, New York, USA; 2New York City Department of Health and Mental Hygiene, 
New York, New York, USA; 3ZevRoss Spatial Analysis, Ithaca, New York, USA; 4Hunter College, City University of New York School of 
Public Health, New York, New York, USA
Ba c k g r o u n d: Recent time-series studies have indicated that both cardiovascular disease (CVD)
mortality and hospitalizations are associated with particulate matter (PM). However, seasonal 
patterns of PM associations with these outcomes are not consistent, and PM components respon-
sible for these associations have not been determined. We investigated this issue in New York City 
(NYC), where PM originates from regional and local combustion sources.
oB j e c t i v e: In this study, we examined the role of particulate matter with aerodynamic diameter 
≤ 2.5 µm (PM2.5) and its key chemical components on both CVD hospitalizations and on mortality 
in NYC.
Me t h o d s : We analyzed daily deaths and emergency hospitalizations for CVDs among persons 
≥ 40 years of age for associations with PM2.5, its chemical components, nitrogen dioxide (NO2), 
carbon monoxide, and sulfur dioxide for the years 2000–2006 using a Poisson time-series model 
adjusting for temporal and seasonal trends, temperature effects, and day of the week. We estimated 
excess risks per interquartile-range increases at lags 0 through 3 days for warm (April through 
September) and cold (October through March) seasons.
re s u l t s: The CVD mortality series exhibit strong seasonal trends, whereas the CVD hospitalization 
series show a strong day-of-week pattern. These outcome series were not correlated with each other 
but were individually associated with a number of PM2.5 chemical components from regional and 
local sources, each with different seasonal patterns and lags. Coal-combustion–related components 
(e.g., selenium) were associated with CVD mortality in summer and CVD hospitalizations in win-
ter, whereas elemental carbon and NO2 showed associations with these outcomes in both seasons.
co n c l u s i o n: Local combustion sources, including traffic and residual oil burning, may play a year-
round role in the associations between air pollution and CVD outcomes, but transported aerosols 
may explain the seasonal variation in associations shown by PM2.5 mass.
key w o r d s : air pollution, chemical species, New York City, particulate matter, traffic. Environ 
Health Perspect 119:467–473 (2011).  doi:10.1289/ehp.1002667 [Online 17 December 2010]Ito et al.
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Ostro et al.(2007) analyzed data from nine 
California counties and reported an associa­
tion between cardiovascular mortality and 
several chemical components, including EC, 
organic carbon (OC), nitrate (NO3), iron, and 
potassium, at various lags. Peng et al. (2009) 
examined associations between elderly hos­
pital admissions and seven PM2.5 chemical 
constituents that contributed substantive mass 
fractions to overall mass (EC, OC, SO4, NO3, 
Na+, Si, and ammonium ion) in 119 U.S. cit­
ies and found that EC was significantly associ­
ated with CVD hospitalizations. These studies 
either did not examine the PM2.5 chemical 
species whose mass contributions were low 
(e.g., Ni, V) or conduct analyses in the cities 
where the levels of these species were low.
The mortality and hospitalization studies 
noted above have examined the same or similar 
range of categories based on the International 
Classification of Diseases, 9th Revision [ICD­9; 
World Health Organization (WHO) 1977] 
and 10th Revision (ICD­10; WHO 2007) for 
CVD, but none of them examined both CVD 
mortality and hospitalizations in the same anal­
ysis or compared how these two CVD out­
comes relate to each other or to other covariates 
in the regression models. Investigation of the 
apparent discrepancy in seasonal and regional 
pattern of associations between PM and these 
outcomes would benefit from a direct compari­
son of these CVD outcomes and characteriza­
tions of their relationships to PM2.5 chemical 
constituents and other pollutants.
The objective of our analysis was to exam­
ine the role of key PM2.5 chemical constituents 
on both CVD hospitalizations and mortality 
in NYC. NYC has one of the nation’s highest 
levels of Ni, presumably from the combus­
tion of relatively “dirty” residual oils in large 
buildings for space heating (Peltier et al. 2009), 
as well as from the ships in the Port of New 
York ship terminals in Newark and Elizabeth, 
New Jersey, that burn so­called “bunker fuels,” 
which are heavy residual oils. NYC also has 
the nation’s highest density of traffic. In addi­
tion, during warm seasons, a major fraction 
(50–80%) of PM2.5 in NYC is transported 
secondary SO4 and associated chemical con­
stituents (Lall and Thurston 2006). NYC’s very 
large population also provided sufficient statis­
tical power to examine the association between 
the CVD outcomes and PM2.5 chemical spe­
ciation data that were collected every third day.
Materials and Methods
Cardiovascular hospitalization and mortality 
data. Hospitalizations and mortality data for five 
boroughs (Manhattan, Brooklyn, Queens, the 
Bronx, and Staten Island) of NYC for the years 
2000 through 2006 were available at the New 
York City Department of Health and Mental 
Hygiene (NYCDOHMH). The hospitalization 
discharge data were from the Statewide Planning 
and Research Cooperative System of New York 
State. The relevant variables available in the 
electronic discharge abstract for each patient 
included date of admission, age, sex, and primary 
ICD­9 discharge diagnosis code. The mortality 
records were obtained from the New York City 
Office of Vital Statistics. The following variables 
were used in our study: date of death, age, and 
the ICD­10 codes for underlying cause of death. 
We extracted hospitalization records whose type 
of admission was “emergency” or “urgent” only. 
For both hospitalizations and deaths, we aggre­
gated daily counts for those ≥ 40 or more years 
of age for the following categories: hyperten­
sive diseases (ICD­9, code 402; ICD­10, code 
I11); myocardial infarction (ICD­9, code 410; 
ICD­10, codes I21–I22); ischemic heart dis­
ease (ICD­9, code 414; ICD­10, code I25); 
dysrhythmias (ICD­9, code 427; ICD­10, code 
I48); heart failure (ICD­9, code 428; ICD­10, 
code I50); and stroke (ICD­9, codes 430–439; 
ICD­10, codes I60–I69). As expected, no mor­
tality counts were found for dysrhythmias. We 
combined the daily counts for these specific 
causes for overall CVD mortality and overall 
CVD hospitalizations and used them for our 
main analysis but also examined the specific 
CVD series separately to check consistency of 
their results with the overall series.
Air pollution and weather data. Data for 
PM2.5, NO2, CO, and SO2 were retrieved 
from the U.S. EPA Air Quality System (U.S. 
EPA 2008). Our previous study in NYC (Ito 
et al. 2007) found that PM2.5 and NO2 show 
generally high monitor­to­monitor temporal 
correlations, whereas CO and SO2 show gener­
ally poor monitor­to­monitor temporal cor­
relations such that excluding certain monitors 
was not meaningful. Therefore, all available 
monitors within the five boroughs of NYC for 
these pollutants were included, and the aver­
age of data from multiple monitors was com­
puted using the 24­hr average values. There 
were only three U.S. EPA PM2.5 chemical spe­
ciation monitors; our previous analysis of tem­
poral correlations of PM2.5 chemical species 
at these three monitors (two in the Bronx and 
one in Queens, several miles apart) found that 
the extent of monitor­to­monitor correlation 
varied across chemical species, with higher cor­
relations for the species associated with regional 
pollution and lower correlations for the spe­
cies associated with local pollution (Ito et al. 
2004). However, there was no clear justifica­
tion for excluding certain monitors given the 
Table 1. Distribution of daily CVD mortality and hospitalization, weather, and air pollution variables.
All year Warm season Cold season
Variable Mean ± SD IQRa Mean ± SD Mean ± SD
Mortality (counts/day)
Hypertension 3.5 ± 2.0 3.0 3.3 ± 1.9 3.6 ± 2.0
Myocardial infarction 10.7 ± 3.8 5.0 9.9 ± 3.7 11.5 ± 3.8
Ischemic heart disease 42.1 ± 8.2 11.0 39.4 ± 7.1 44.8 ± 8.4
Heart failure 1.7 ± 1.4 2.0 1.7 ± 1.3 1.8 ± 1.4
Stroke 1.8 ± 1.4 2.0 1.8 ± 1.4 1.9 ± 1.4
CVD (sum of above) 59.8 ± 10.4 13.0 56.0 ± 8.7 63.7 ± 10.6
Hospitalizations (counts/day)
Hypertension 5.5 ± 2.9 4.0 5.3 ± 2.9 5.6 ± 2.9
Myocardial infarction 41.0 ± 9.0 12.0 39.6 ± 8.5 42.4 ± 9.3
Ischemic heart disease 64.6 ± 25.2 47.0 64.9 ± 24.9 64.3 ± 25.5
Dysrhythmia 41.0 ± 11.1 17.0 41.6 ± 11.2 40.4 ± 11.0
Heart failure 74.8 ± 16.5 24.0 72.3 ± 16.2 77.4 ± 16.4
Stroke 54.4 ± 9.7 13.0 54.8 ± 9.4 54.0 ± 10.0
CVD (sum of above) 281.3 ± 58.8 106.0 278.6 ± 58.1 284.0 ± 59.5
Weather (°C)
Temperature 13.2 ± 9.49 16.04 20.22 ± 6.08 6.16 ± 6.67
Dew point 5.81 ± 10.18 16.57 12.78 ± 6.8 –1.18 ± 7.97
Apparent temperature 12.6 ± 10.96 19.32 20.73 ± 8.04 4.44 ± 6.56
PM2.5/components (µg/m3)
PM2.5 14.44 ± 8.53 10.0 14.79 ± 8.99 14.09 ± 8.02
EC 1.13 ± 0.56 0.62 1.03 ± 0.51 1.24 ± 0.58
OC 4.3 ± 2.28 2.38 4.51 ± 2.62 4.08 ± 1.83
SO4 4.14 ± 3.29 3.19 4.81 ± 4.01 3.42 ± 2.04
NO3 2.12 ± 1.98 2.19 1.52 ± 1.32 2.78 ± 2.33
Na+ 0.14 ± 0.11 0.11 0.14 ± 0.1 0.15 ± 0.11
Ni 0.0171 ± 0.0133 0.0144 0.0111 ± 0.0097 0.0236 ± 0.0136
V 0.0066 ± 0.0045 0.0053 0.0054 ± 0.0035 0.0080 ± 0.0050
Zn 0.0300 ± 0.0208 0.0194 0.0216 ± 0.0116 0.0389 ± 0.0245
Si 0.0769 ± 0.0712 0.0543 0.0886 ± 0.0898 0.0643 ± 0.0394
Se 0.0013 ± 0.0012 0.0013 0.0011 ± 0.0010 0.0015 ± 0.0014
Br 0.0036 ± 0.0025 0.0031 0.0031 ± 0.0020 0.0040 ± 0.0028
Gaseous pollutants
NO2 (ppb) 28.7 ± 8.8 11.5 27.5 ± 8.6 30.0 ± 8.9
SO2 (ppb) 7.4 ± 6.1 6.6 3.9 ± 2.6 10.8 ± 6.7
CO (ppm) 1.0 ± 0.43 0.5 0.94 ± 0.35 1.06 ± 0.49
aIQRs for pollution variables on this table were used for the risk calculation.Cardiovascular effects of particulate matter components
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closeness of the monitors. Therefore, we also 
used the average of the three monitors’ data 
for this analysis. The sampling frequency of the 
chemical speciation data was every third day. 
This procedure resulted in a reduced sample 
size for PM components compared with other 
pollutants. The 24­hr average temperature and 
dew point for LaGuardia Airport were obtained 
from the National Oceanic and Atmospheric 
Administration, National Climatic Data Center 
(2009) Global Summary of the Day database.
More than 40 PM2.5 chemical species were 
available, but many of them had high percent­
ages of observations below their detection lim­
its or poor monitor­to­monitor correlations. 
Also, many species were of no interest in terms 
of source identification or suspected toxicity. 
Therefore, we selected the following key PM2.5 
chemical components based on past source­
apportionment studies in NYC (e.g., Ito et al. 
2004; Lall and Thurston 2006; Qin et al. 2006) 
and recent health effects studies discussed in 
the introductory remarks: EC, OC, Ni, V, zinc 
(Zn), SO4, selenium (Se), Br, NO3, and Na+.
Exploratory data analysis. We conducted 
several exploratory data analyses to describe 
and characterize the difference in temporal 
patterns between CVD hospitalizations and 
mortality and their relationships to weather 
and air pollution.
To characterize relative variance contribu­
tions from seasonal trends, day­of­week, and 
random components to the overall time series, 
we conducted spectral analysis of CVD hospital­
izations and mortality. We used modified Daniel 
smoothers to smooth periodograms, applying 
several spans of smoothing over frequency, as 
suggested by Venables and Ripley (2002).
To characterize bivariate temporal rela­
tionships among weather, air pollution, and 
health outcome variables, we computed the 
cross­correlation function (CCF; correlation 
with lags) for key variables considered. These 
cross­correlations can indicate the sequence of 
temporal fluctuations (i.e., which variable leads 
the other in time). The correlation between 
two time series can be strongly influenced by 
shared trends, seasonal cycles, and day­of­week 
patterns that may be confounding. Therefore, 
in order to remove the influence of these tem­
poral patterns and to focus on the short­term 
relationships between the variables, each time 
series was first prefiltered in a generalized lin­
ear model using a natural cubic spline smooth­
ing function with 8 degrees of freedom per 
year and a day­of­week variable. A CCF was 
then computed using pairwise complete obser­
vations between the lagged residual time series. 
We chose 8 degrees of freedom per year to be 
consistent with the extent of adjustment for 
temporal trends in recent multicity time­series 
analyses (e.g., Bell et al. 2009; Samoli et al. 
2008). Because relationships among these 
variables can change across seasons, the CCF 
was computed in a series of 12 three­month 
blocks centered on each month of the year and 
pooled for the entire 7­year study period.
Regression models. We estimated percent 
excess risk (%ER) for air pollutants using a 
Poisson time­series model, adjusting for 
temporal trends and seasonal cycles, immedi­
ate and delayed temperature effects, and day 
of the week. The extent of lagged days con­
sidered for air pollution and weather variables 
were based mainly on recent time­series stud­
ies and the exploratory analysis of these data 
described above. We used natural cubic splines 
of days to adjust for potentially confounding 
temporal trends and seasonal cycles using 8 
degrees of freedom per year in our base model. 
To adjust for immediate and delayed nonlin­
ear temperature effects, our base model also 
included natural cubic splines of the same­
day and the average of past 1­ through 3­day 
lagged temperature with 3 degrees of freedom 
over the range for each term. Temperature and 
dew point were highly correlated (r = 0.93) 
in this data set, so we did not include them 
simultaneously. We did, however, compute 
apparent temperature from temperature and 
dew point (Steadman 1979) and included it 
in a separate alternative model for sensitivity 
analysis. Risks were estimated at lags 0 through 
3 days for interquartile­range (IQR) increases 
of pollutants for all­year data (Table 1) and for 
all­year, warm (April through September), and 
cold (October through March) seasons. All the 
statistical analyses were conducted using the R 
statistical software package (version 2.10.1; R 
Development Core Team 2009).
Results
CVD mortality and hospitalization time series 
exhibited markedly different characteristics. 
Figure 1 shows time series and corresponding 
Figure 1. Time-series plots and power spectra of CVD mortality (A) and hospitalizations (B), with associated power spectra. Power spectra were estimated using 
modified Daniel smoothers over five and then seven frequencies; the bars in the upper right corner indicate 95% confidence bands of spectra.
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power spectra of these time series. CVD mor­
tality showed a strong seasonal pattern, with 
broad winter peaks that vary from year to 
year, apparently reflecting influenza epidem­
ics. A day­of­week pattern was not apparent 
in the CVD mortality power spectra, which 
showed a major variance contribution in the 
frequency range corresponding to seasonal 
cycles. In contrast, CVD hospitalizations 
showed substantial variance contribution 
from day­of­week cycle frequencies (0.14/day 
or 7­day cycle, and its harmonics), which is 
stronger than that from seasonal cycles. CVD 
hospitalizations were lower on Saturday and 
Sunday, with hospitalizations about 60% 
higher on Monday than on Sunday. Likewise, 
the power spectra for specific CVD hospital­
izations all showed strong day­of­week peaks 
that were stronger than those for seasonal 
cycles (data not shown).
Table 1 shows distributional characteris­
tics of CVD outcome, weather, and air pol­
lution variables. The largest fraction of CVD 
mortality was from ischemic heart disease, 
followed by myocardial infarction. CVD hos­
pitalizations were more evenly divided by the 
specific categories. Ni, V, Zn, and SO2, all 
likely associated with residual oil burning, 
showed substantially higher levels in cold 
seasons than in warm seasons. Correlations 
among air pollutants by season are shown in 
Supplemental Material, Table 1 (doi:10.1289/
ehp.1002667).
The following results from CCF and 
regression analysis necessarily involve multiple 
testing because of multiple lags, pollutants, 
and outcomes examined. Therefore, to guard 
against overinterpretation of chance findings, 
we focus not on the statistical significance of 
individual results but instead on identifying 
consistent patterns and contrasts of results 
across the lags, pollutants, and outcomes.
In the CCF analysis of key variables, after 
removing seasonal cycles and day­of­week pat­
terns, temperature showed different patterns of 
associations with CVD mortality versus CVD 
hospitalizations, respectively (Figure 2A,B). 
With CVD mortality, temperature showed 
positive associations in summer and lagged 
negative associations in winter, consistent with 
fairly well­known mortality impacts of tem­
perature reported in the past literature (e.g., 
Curriero et al. 2002). In contrast, CVD hos­
pitalizations showed immediate and positive 
associations with temperature in the cold sea­
son, clearly not heat events, and biologically 
implausible. There was also a suggestion of 
lagged negative associations between tempera­
ture and CVD hospitalizations in the warm 
season and the beginning of the cold season. 
We repeated the analysis using apparent tem­
perature rather than temperature (data not 
shown), but the pattern and magnitude of 
associations were essentially unchanged.
The CCF relationships between PM2.5 
and CVD mortality and hospitalizations also 
showed contrasting patterns (Figure 2C,D). 
PM2.5 was positively associated with CVD 
mortality in the warm season with lags 0 and 
1 day, whereas it was positively associated 
with CVD hospitalizations in the cold season, 
most consistently at lag 0 day. The CCF for 
chemical components of PM2.5 versus CVD 
outcomes showed less distinct patterns (data 
not shown), likely in part due to the smaller 
sample size (only every third day). The CCF 
relationship between temperature and PM2.5 
chemical components showed generally posi­
tive associations on the same day throughout 
the year and delayed negative associations in 
cold seasons, but the relationship between tem­
perature and Ni showed negative associations 
with longer lags and no positive associations 
in the cold season [Supplemental Material, 
Figure 1d (doi:10.1289/ehp.1002667)].
We found no correlation between CVD 
hospitalizations and CVD mortality, except 
for as weak negative correlation in the cold 
season (Figure 2E). This is consistent with the 
contrasting relationships between these CVD 
outcomes and temperature or PM2.5. The 
CCFs between specific CVD hospitalizations 
Figure 2. Cross-correlation function (CCF) between X = temperature, Y = CVD mortality (A); X = temperature, 
Y = CVD hospitalizations (B); X = PM2.5, Y = CVD mortality (C); X = PM2.5, Y = CVD hospitalizations (D); and 
X = CVD hospitalizations, Y = CVD mortality (E): a correlation below the centerline (lag 0) indicates that X 
leads Y, and a correlation above the centerline indicates that Y leads X. Black bars are positive correlations, 
and white bars are negative correlations (correlations whose absolute values are < 0.1 are not shown). The 
lengths of reference correlations (0.25 and 0.50) are also shown. CCFs were computed after removing sea-
sonal trends and day-of-week pattern (see “Results”). Abbreviations: X, predictor; Y, outcome.
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and corresponding CVD mortality (e.g., CCF 
between heart failure hospitalizations and 
heart failure mortality) likewise did not show 
associations (data not shown).
Figure 3 shows air pollution–CVD mor­
tality regression results (see Table 1 for IQRs 
used to compute %ER). PM2.5 was associated 
with CVD mortality in the warm season at 
lag 0 [%ER = 2.0%; 95% confidence inter­
val (CI), 0.7–3.3; per 10 µg/m3] and lag 1 
day (1.9%; 95% CI, 0.8–3.1) and in the cold 
season at lag 1 day (1.0%; 95% CI, –0.1 to 
2.2). OC and SO4, both of which are asso­
ciated with a major mass fraction of PM2.5 
during the warm season (i.e., secondary aero­
sols), also showed significant associations with 
CVD mortality in the warm season at lags 0 
and 1 days, with estimated %ERs similar to 
those for PM2.5 per IQR increase. Se, primar­
ily associated with transported coal emissions 
in the eastern United States, and also associ­
ated with transported SO4, showed a strong 
association with CVD mortality at lag 1 day. 
EC was significantly associated with CVD 
mortality at lag 1 day in the warm season and 
was nearly significant in the cold season also at 
lag day 1. Br (perhaps associated with traffic) 
was strongly associated with CVD mortality 
at lag 0 in the warm season. Ni, V, and Zn 
(the elements most associated with residual oil 
burning in NYC) showed a similar pattern of 
associations with CVD mortality, with stron­
ger associations in the cold season at lag 3 days. 
Na+ (considered to be a signature element for 
sea salt) also showed nearly a significant posi­
tive association at lag 0 day in both warm and 
cold seasons. Among the gaseous pollutants, 
NO2 showed lag 1­day positive associations 
with CVD mortality in both warm and cold 
seasons. There are peculiar negative (signifi­
cant or nearly significant) associations for a 
number of pollutants at lag 0 day in the cold 
season (PM2.5, OC, Ni, Zn, Si, Se, NO3, 
NO2, SO2, and CO). These pollutants were 
not negatively correlated with CVD mortality 
in the CCF analysis (data not shown), and the 
negative associations may be induced by the 
adjustment for temperature. Not surprisingly, 
among the specific CVD mortality categories, 
mortality for ischemic heart disease showed a 
similar pattern of association as that for total 
CVD mortality (data not shown).
The relationships between air pollutants 
and CVD hospitalizations showed a pattern 
of association different than that for CVD 
mortality (Figure 4). The associations between 
air pollution and CVD hospitalizations, in 
contrast to CVD mortality, were generally 
stronger in the cold season than in the warm 
season. The exceptions were EC, NO2, SO2, 
and CO, which showed similar magnitude 
and lag structure of associations in both sea­
sons. PM2.5 exhibited the strongest association 
at lag 0 day in the cold season (%ER = 1.1; 
95% CI, 0.2–2.0), and most of the PM2.5 
chemical components that showed significant 
or near significant associations (OC, SO4, Ni, 
Zn, Si, Se, and Br) with CVD hospitaliza­
tions showed the strongest associations at lag 
0 day in the cold season. Of the specific CVD 
hospitalizations, those for hypertensive dis­
ease, ischemic heart disease, dysrhythmias, and 
stroke showed patterns of associations similar 
to that for total CVD hospitalizations (data 
not shown). Seasonal patterns of associations, 
lags, source types, and %ER are summarized 
for CVD mortality and hospitalizations in 
Supplemental Material, Table 2 (doi:10.1289/
ehp.1002667).
These results were not sensitive to the alter­
native model in which we used apparent tem­
perature, rather than temperature, to adjust for 
weather effects. Supplemental Material, Figure 
2 (doi:10.1289/ehp.1002667), shows com­
parisons of risk estimates for CVD mortality 
and hospitalizations using temperature and 
apparent temperature for the warm and cold 
Figure 3. %ER for CVD mortality per IQR increase in air pollutant, adjusted 
for temporal trend, day-of-week, same-day, and delayed temperature effects.
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Figure 4. %ER for CVD hospitalizations per IQR increase in air pollutant, adjusted 
for temporal trend, day-of-week, same-day, and delayed temperature effects.
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seasons. There appears to be no systematic 
difference in the risk estimates obtained from 
these models.
Discussion
We found that adult CVD mortality and 
emergency CVD hospitalizations time series, 
when constructed with consistent ICD catego­
ries, were not correlated over time. The CVD 
mortality series showed a strong influence of 
seasonal cycles and influenza, whereas CVD 
hospitalizations were strongly influenced by a 
day­of­week pattern, with little seasonal pat­
tern. Their relationships with temperature, 
as examined in our seasonal CCF analysis, 
were also different. The strong influence of the 
day­of­week pattern seen in CVD hospitaliza­
tions (lower counts on weekends) may imply 
that they are more strongly influenced by 
behavioral modification factors than by CVD 
mortality (e.g., being able to delay seeking 
treatment over the weekend). Also, it is possi­
ble that coding practice and conditions under 
which a “primary cause” is assigned to these 
outcomes may be different. For example, if a 
person with a chronic ischemic heart condition 
dies with an additional complication of influ­
enza­related pneumonia, the primary cause of 
death may still be recorded as a heart­disease–
related cause, whereas when a person with an 
acute cardiovascular condition is admitted to 
a hospital through the emergency department, 
the primary cause may be less ambiguous. If 
such differences contribute to the apparent 
lack of correlation between these two CVD 
outcomes, then the subgroups at risk for PM 
effects within these CVD outcomes need not 
share the same risk characteristics or even the 
same mechanism(s) of PM effects. However, 
in this analysis, we did not specifically examine 
whether some of those who were hospitalized 
died later, or whether a subgroup’s hospitaliza­
tions were associated with air pollution. If the 
fraction of each subgroup is relatively small in 
the overall CVD hospitalizations, then we may 
not see significant lagged correlation between 
CVD hospitalizations and mortality, whether 
or not they are associated with air pollution in 
the same causal pathway.
CVD mortality’s immediate association 
with high temperature in the warm season 
and lagged association with cold temperature 
in the cold season found in our analysis are 
consistent with expectation and the past lit­
erature. However, the lack of heat effects on 
CVD hospitalizations in warm seasons and 
the presence of positive associations in cold 
seasons (i.e., the warmer the temperature, the 
more CVD hospitalizations) found in this 
study is somewhat surprising, although it is in 
part consistent with “a protective effect of cold 
temperature” (i.e., the lack of the left side of 
the U­shape in the temperature–outcome rela­
tionship) that was reported by Schwartz et al. 
(2004) who analyzed temperature and elderly 
CVD hospitalizations in 12 U.S. cities. Also, 
in another analysis of CVD hospitalizations in 
NYC, whereas the overall CVD hospitaliza­
tions were positively associated with high tem­
perature, the hospitalizations for CVD, heart 
failure, and hypertension showed negative risk 
estimates (Lin et al. 2009). Thus, there may 
be heterogeneity in temperature effects within 
subcategories of CVD hospitalizations.
In these analyses, CVD mortality was 
more strongly associated with PM2.5 in the 
warm season than in the cold season, whereas 
CVD hospitalization was more strongly asso­
ciated with PM2.5 in the cold season than in 
the warm season. These findings are consis­
tent with the results of the analysis in the U.S. 
Northeast of (all­cause) mortality and PM10 
(Peng et al. 2005) and the analysis of CVD 
hospitalizations and PM2.5 (Bell et al. 2008). 
The lag structures of PM2.5 associations for 
CVD mortality (lags 0 and 1 day) and CVD 
hospitalizations (lag 0 day) are consistent with 
those found in past multicity studies for mor­
tality (Peng et al. 2005) and CVD hospitaliza­
tions (Bell et al. 2008; Dominici et al. 2006; 
Peng et al. 2009).
The patterns of lagged associations between 
individual PM2.5 chemical components and 
CVD mortality were not always consistent 
with those for PM2.5 mass concentrations. It 
is not surprising that SO4 and OC were asso­
ciated with CVD mortality on the same lag 
days (0 and 1) as PM2.5 because both SO4 and 
OC contribute major mass fractions to PM2.5. 
Si, a marker of soil whose associated species 
together contribute significant amounts of par­
ticle mass, also showed the same lag structure 
of associations. However, other PM chemical 
components with smaller mass contributions 
showed different lagged associations with CVD 
mortality compared with PM2.5. Ni, V, and 
Zn (i.e., the species associated with residual oil 
burning in NYC) all showed delayed associa­
tions (largest estimates at lag 3 days) with CVD 
mortality. However, this may reflect the rela­
tionship between temperature and these species 
in the cold season [see Supplemental Material, 
Figure 1 (doi:10.1289/ehp.1002667)], which 
was negative with long lags and had no posi­
tive associations on the same day. Therefore, 
caution is required in interpreting these 
lagged associations between PM components 
and health outcomes, because they may have 
varying relationships with other covariates in 
the regression model. Also, the 3­day lagged 
association between Ni and CVD mortality 
is not necessarily consistent with Ni’s effect 
modification of 1­day lagged PM10–mortality 
associations suggested in Lippmann et al.’s 
(2006) result.
We observed the associations between 
CVD hospitalizations with air pollutants pri­
marily in the cold season, except for EC, Na+, 
NO2, SO2, and CO, which were associated 
in both seasons. Because most of the PM2.5 
chemical components and gaseous pollut­
ants examined similarly yielded significant or 
nearly significant associations at lag 0 day, it is 
difficult to draw inferences on which chemical 
components or sources may be more impor­
tant for the PM2.5 association with CVD hos­
pitalizations in this data set. These results are, 
in part, consistent with the significant effect 
modifiers (EC and Ni) of PM2.5 effects on 
elderly CVD hospitalizations reported in the 
Bell et al. (2009) analysis or those (Br and Ni) 
reported in the Zanobetti et al. (2009) analy­
sis but show a broader spectrum of PM2.5 
source components contributing to effects.
Given the lack of correlation between 
CVD hospitalizations and CVD mortality over 
time, we did not expect “coherence” in specific 
PM2.5 chemical components’ association with 
these two CVD outcomes. Of the pollutants 
examined, EC and NO2 showed the most con­
sistent associations with these CVD outcomes, 
in that these pollutants showed the same extent 
of associations in both warm and cold seasons 
with the same lags (lag 1 day for CVD mortal­
ity and lag 0 day for CVD hospitalizations). 
Both EC and NO2 are often considered to be 
“signature” tracers for traffic sources. However, 
EC may be emitted from other fuel combus­
tions, including oil boiler emissions (Schauer 
2003). Likewise, NO2 is also emitted from a 
variety of combustion sources. In fact, in the 
New York City Community Air Survey con­
ducted during the winter of 2008 and 2009, 
which measured PM2.5, its chemical compo­
nents, and gaseous pollutants at 150 locations 
in NYC, land­use regression analysis found 
that both traffic and building density (i.e., 
proxy for building space heating) were signifi­
cant predictors of EC and NO2 in this city 
(NYCDOHMH 2009). This does not directly 
imply that these pollutants per se are respon­
sible for the health effects, but they may be 
important indicators of sources relevant to the 
PM2.5 effects on CVD outcomes.
The relative significance of the associations 
of the PM components with CVD outcomes 
could have been influenced by their corre­
sponding exposure misclassification errors that 
include the error associated with the locations 
of monitors relative to the population. An 
investigation related to this issue involving 
the same three speciation monitors (Ito et al. 
2004) found that the PM2.5 chemical spe­
cies associated with regional secondary aero­
sols (e.g., SO4 and NO3) tend to have higher 
monitor­to­monitor temporal correlations 
than do the species associated with more local 
combustion sources (e.g., EC and Ni). Thus, 
the interpretation of our study findings is lim­
ited by the uncertainty regarding the influence 
of relative exposure error across the species on 
the observed associations.Cardiovascular effects of particulate matter components
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Conclusion
We found that CVD hospitalizations and 
CVD mortality time series are not correlated, 
but they are each independently associated 
with a number of PM2.5 chemical compo­
nents, including both regional secondary aero­
sols and local combustion sources. EC and 
NO2 showed the most consistent associa­
tions with these CVD outcomes throughout 
the year, but the PM components associated 
with the regional transported aerosols from 
coal combustion (Se and SO4) exhibited the 
season­specific association pattern most simi­
lar to that of PM2.5 mass. We conclude that 
local combustion sources, including traffic and 
residual oil burning, may be important sources 
affecting CVD adverse effects in NYC.
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